Financial Year |
March 31 2023 |
Monetary Funds |
183,325,410.40 |
Held-for-trading Financial Assets |
115,000,000.00 |
Notes Receivable |
-- |
Accounts Receivable |
71,672,589.98 |
Advances to Suppliers |
2,680,126.19 |
Other Receivables |
4,939,970.83 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
56,595,071.91 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
1,142,441.63 |
Total Current Assets |
472,665,936.43 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
248,722,946.38 |
Under-construction Projects |
38,244,852.34 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
12,779,517.66 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
1,754,061.86 |
Other Non-Current Assets |
22,217,554.88 |
Sub-Total of Non-Current Assets |
346,752,209.54 |
Total Assets |
819,418,145.97 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
52,074,826.17 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
10,496,487.47 |
Taxes Payable |
12,186,374.50 |
Interest Payable |
23,978.48 |
Dividend Payable |
-- |
Other payables |
1,381,218.81 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
21,500,000.00 |
Other Current Liabilities |
677,385.78 |
Sub-Total of Current Liabilities |
103,740,120.52 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
55,384,826.00 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
55,711,905.60 |
Total Liabilities |
159,452,026.12 |
Paid-In Capital(Or Share Stock) |
144,360,000.00 |
Capital Surplus |
223,200,943.00 |
Surplus Reserve |
41,323,848.41 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
250,950,763.63 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
659,966,119.85 |
Owner's Equity(Stockholder's Equity) |
659,966,119.85 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
819,418,145.97 |